Report #2857724

Received Sep 10, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Male
Age: Age unknown
State: WA
Recovered: Unknown
Vaccinated: Apr 17, 2025
Onset: Apr 17, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
HEP	HEP B (HEPLISAV-B)	DYNAVAX TECHNOLOGIES CORPORATION	1	946063	IM / RA

Symptoms (1)

No adverse event

Symptom narrative

Given HEPLISAV-B When They were 14 Years Old; Initial report received on 06-Aug-2025. A pharmacist reported that a 14-year-old male received HEPLISAV-B (hepatitis B vaccine) for hepatitis B immunization. No medical history or concomitant medications were reported. On 17-Apr-2025, the patient received a dose of a hepatitis B vaccine HEPLISAV-B (lot number 946063, expiration date 31-Aug-2027; NDC number not available) intramuscularly in the right arm. The patient was 14 years old at the time of immunization. No side effects were reported. No other information was available. Company Comment: : The company assessed the event as non-serious.; Sender's Comments: : The company assessed the event as non-serious.